Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...
which spun out of Pfizer in 2018. The $45-per-share agreement gives AbbVie a pipeline of CNS drugs headed by emraclidine (formerly CVL-231), a drug for schizophrenia with a new mechanism of action ...
The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to fend off criticism from an activist investor that has argued the ...
Pfizer’s JAK/TEC inhibitor Litfulo has been ... backed Litfulo for patients aged 12 and over with the autoimmune disorder, which attacks the hair follicles across the body, including the scalp ...
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback